Company Search:
Advanced Search
Sponsored Links
Jounce Therapeutics Inc Company Snapshot
Jounce Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jounce Therapeutics Inc with three other companies in this sector in the United States: Principia Biopharma Inc (2018 sales of $69.14 million of which 100% was Biopharmaceutical), Spark Therapeutics Inc ($64.73 million of which 100% was Healthcare Services), and Cytomx Therapeutics Inc ($59.50 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Jounce Therapeutics Inc
  Stock Performance Chart for Jounce Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 7.79
(Figures in U.S. Dollars)
1 Week 44.0%   13 Weeks 91.9%  
4 Weeks 120.1%   52 Weeks 97.2%  
Jounce Therapeutics Inc Key Data:
  Ticker: JNCE Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 65,201,000
(Year Ending Jan 2019).
Employees: 115
  Currency: U.S. Dollars Market Cap: 258,814,960
  Fiscal Yr Ends: December Shares Outstanding: 33,224,000
  Share Type: Common Closely Held Shares: 4,392,336
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.